Saving Lives with Data

Delivering the health data and analytics the world deserves now.

Empowering researchers with the first data and analytics solution to study patient care and outcomes.

The most timely, complete, and highest quality data on US health

“Truveta will enable us to gather insights on a breadth of devices and disease states, including peripheral artery disease, venous thromboembolic disease and segments of interventional oncology. The first analysis will focus on gaining a deeper understanding of the long-term patient outcomes relating to the use of our products indicated for treatment of peripheral artery disease and will enable us to further our commitment to addressing the disparities in access to healthcare that exist across various patient populations and demographics.”

Michael R. Jaff, DO

Chief Medical Officer and Vice President, Medical Affairs, Innovation and Technology, Peripheral Interventions, Boston Scientific

Truveta Studio empowers researchers to discover insights on yesterday's care, today

Healthcare is challenged by inaccessible, fragmented, and outdated data. Truveta Studio is an integrated solution that combines data and analytics to accelerate learning in real time.
Watch Truveta CEO Terry Myerson, COO Lisa Gurry, and CTO Jay Nanduri describe the power of Truveta Studio
Microsoft and Truveta Announcement
Watch Truveta CEO Terry Myerson, COO Lisa Gurry, and CTO Jay Nanduri describe the power of Truveta Studio

Unprecedented data

^

Daily updated clinical data, for the most current view of US health

^

Representative of the US, with de-identified longitudinal journeys for each patient

^

Full patient medical records linked across providers with mortality, comprehensive SDOH, and claims data

Fast, clinical insights

^

Computable medical concepts in seconds

^

Accelerated collaboration and learning

^

Convenient analysis with integrated statistics and visualization libraries

Unlimited discovery

^

Subscriptions for daily updated data

^

Unlimited analytics and unlimited users

^

Complete and integrated analytics solution

Formed and governed by US healthcare

Healthcare is deeply challenged by inaccessible, fragmented, and unstructured data. Clinical trials take many years to complete, are very expensive, and lack appropriate diversity, leaving critical evidence gaps in medicine.

Motivated by the lack of useful data on how best to respond during COVID-19, 27 health systems providing 16% of all US healthcare, formed Truveta. Data from Truveta’s members is normalized, de-identified, and made available for research.

Hear from innovative health system leaders about why they joined together to form Truveta.
Microsoft and Truveta Announcement

Hear from innovative health system leaders about why they joined together to form Truveta.

“Information is key to solving many of the most challenging healthcare problems. With Truveta, we will have a secure, de-identified nationwide data system, representative of diverse populations, helping us get to discovery faster. This will enable us to provide better care to our communities and save lives with data.”

Portrait of Rod Hochman, M.D.

Rod Hochman, M.D.

President & CEO

Latest research insights

Red card: Soccer injuries by the numbers

Today we continue our series of sports injury-related insights. Truveta Research first started looking at sports-related injuries following Damar Hamlin’s cardiac event during Monday Night Football on January 2, and after exploring in Truveta Studio, we shared that...

March Madness: Basketball injuries by the numbers

Today we kick off a series of sports injury-related insights. Truveta Research first started looking at sports-related injuries following Damar Hamlin’s cardiac event during Monday Night Football on January 2, and after exploring in Truveta Studio, we shared that...

LinkedIn Live: Truveta Research discusses recent maternal heart health study

The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color more than white women. This February, in honor of Heart Health Month and Black History Month, Truveta...
Bar graphic with text: Preeclampsia-related heart failure disproportionately impacts Black mothers

Preeclampsia-related heart failure disproportionately impacts Black mothers

Among women with preeclampsia, new Truveta Research findings show that Black women are two times more likely to experience heart failure than white women.  Maternal health outcomes in the US are worse than in many other high-income countries such as England, France,...

From the blog

The Chronic Kidney Disease Epidemic: A Call to Action for Researchers

Chronic Kidney Disease (CKD) impacts more than 1 in 7 adults in the United States, totaling roughly 37 million people. March is National Kidney Disease Month - an important awareness initiative, as up to 90% of those with CKD are unaware of their condition. Data,...

Truveta and Alpine Immune Sciences Announce Strategic Partnership to Access Truveta’s Community to Accelerate Recruitment to Povetacicept Clinical Trials

Today, Truveta and Alpine Immune Sciences, Inc. announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being developed for multiple B cell-mediated autoimmune and inflammatory...

New SDOH data in Truveta Studio provide most complete view of health equity’s influence on patient health and outcomes

Today we are excited to announce that we’ve expanded the de-identified data in Truveta Studio to include 28 additional social drivers of health (SDOH) attributes – such as education, income, housing stability, social support, and more – for nearly 80 million...

LinkedIn Live: Truveta Research discusses recent maternal heart health study

The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color more than white women. This February, in honor of Heart Health Month and Black History Month, Truveta...

The latest on LinkedIn